Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
Since 2021, Alzheimer’s Society of Maldives has worked tirelessly to address the needs of people with dementia and their carers. Through advocacy, collaboration with ADI, and engagement with the Maldivian government, the organisation is playing a key role in the development of the Maldives’ first National Dementia Plan, which is set for launch this year. This milestone highlights the impact of coordinated efforts to improve dementia care in the country.
In 2016 Spominčica – Alzheimer Slovenija started developing the Dementia Friendly Spots (DFS) programme. It is a national education and awareness-raising programme connecting a wide spectrum of organisations in a network of sites providing information about dementia locally. The network of DFS include: police and fire stations, shops, libraries,…
New Zealand's Dementia Declaration is the result of people affected by dementia getting together and identifying what they need to live well.